DXCM

DexCom, Inc.

116.62 USD
-0.02 (-0.02%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

DexCom, Inc. stock is down -10.77% since 30 days ago. The next earnings date is Jul 25, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 19 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 3 PUTs, 7 CALLs. 0% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
12 Jun 18:54 16 Jan, 2026 92.50 PUT 40 125
12 Jun 19:02 16 Jan, 2026 92.50 PUT 40 125
12 Jun 19:04 16 Jan, 2026 155.00 CALL 20 59
14 Jun 18:22 28 Jun, 2024 120.00 CALL 350 30
17 Jun 14:10 28 Jun, 2024 121.00 CALL 175 18
17 Jun 17:56 28 Jun, 2024 121.00 CALL 214 18
17 Jun 17:59 28 Jun, 2024 114.00 PUT 487 10
18 Jun 13:48 16 Jan, 2026 110.00 CALL 20 43
18 Jun 15:47 20 Sep, 2024 105.00 CALL 27 7
18 Jun 15:50 17 Jan, 2025 120.00 CALL 20 689

About DexCom, Inc.

DexCom, Inc. focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system.